metformin has been researched along with Insulin Coma in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Insulin Coma: Severe HYPOGLYCEMIA induced by a large dose of exogenous INSULIN resulting in a COMA or profound state of unconsciousness from which the individual cannot be aroused.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, TY | 1 |
| Li, F | 1 |
| Xiong, ZY | 1 |
| Lalau, JD | 1 |
| Masmoudi, K | 1 |
2 other studies available for metformin and Insulin Coma
| Article | Year |
|---|---|
Frequent reoccurrence of hypoglycemia in a type 2 diabetic patient with insulin antibodies.
Topics: Acarbose; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Glucose; Humans; Hypoglycemia | 2010 |
Unexpected recovery from prolonged hypoglycemic coma: a protective role of metformin?
Topics: Aged; Aged, 80 and over; Blood Glucose; Female; Humans; Hypoglycemic Agents; Insulin Coma; Metformin | 2005 |